$RMNI
Rimini Street, Inc.

2015 Q4 Form 10-Q Financial Statement

#000114420416102796 Filed on May 16, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q1
Revenue $118.2M $0.00
YoY Change
Cost Of Revenue $52.80M
YoY Change
Gross Profit $65.40M
YoY Change
Gross Profit Margin 55.33%
Selling, General & Admin $74.60M $0.00
YoY Change
% of Gross Profit 114.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.450M
YoY Change
% of Gross Profit 2.22%
Operating Expenses $74.50M $0.00
YoY Change
Operating Profit -$9.100M -$9.351K
YoY Change
Interest Expense -$900.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.100M
YoY Change
Pretax Income -$43.90M $0.00
YoY Change
Income Tax $1.500M
% Of Pretax Income
Net Earnings -$45.30M -$9.351K
YoY Change
Net Earnings / Revenue -38.32%
Basic Earnings Per Share
Diluted Earnings Per Share -$537.4K $0.00
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000M $100.0K
YoY Change
Cash & Equivalents $967.4K $0.00
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses $7.951K
Receivables
Other Receivables
Total Short-Term Assets $975.4K $372.0K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $172.6M $300.0K
YoY Change
Total Long-Term Assets $172.6M $28.03K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $975.4K $372.0K
Total Long-Term Assets $172.6M $28.03K
Total Assets $173.6M $400.0K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00
YoY Change
Accrued Expenses $19.97K $8.000K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.97K $400.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $19.97K $400.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.057M $356.3K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$130.7K -$9.351K
YoY Change
Common Stock $532.00 $431.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 562.5K shares
Shareholders Equity -$212.3M $0.00
YoY Change
Total Liabilities & Shareholders Equity $173.6M $372.0K
YoY Change

Cashflow Statement

Concept 2015 Q4 2015 Q1
OPERATING ACTIVITIES
Net Income -$45.30M -$9.351K
YoY Change
Depreciation, Depletion And Amortization $1.450M
YoY Change
Cash From Operating Activities $1.690M $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$1.750M
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $170.8M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -174.5M 100.0K
YoY Change
NET CHANGE
Cash From Operating Activities 1.690M 0.000
Cash From Investing Activities 170.8M
Cash From Financing Activities -174.5M 100.0K
Net Change In Cash -2.060M 100.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $1.690M $0.00
Capital Expenditures -$1.750M
Free Cash Flow $3.440M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-95529 USD
CY2016Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2016Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2016Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1066912 USD
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
161227 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-802394 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1047005 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
75622 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-95529 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
967449 USD
CY2016Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2016Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2015Q2 gpiau Common Units Issued In Initial Public Offering
CommonUnitsIssuedInInitialPublicOffering
17250000 shares
CY2015Q2 us-gaap Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
10960590 USD
CY2015Q2 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
4312500 USD
CY2015Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
6037500 USD
CY2016Q1 gpiau Interest On Dissolution Expenses
InterestOnDissolutionExpenses
100000 USD
CY2016Q1 gpiau Reduction Of Intangible Assets Due To Redemption
ReductionOfIntangibleAssetsDueToRedemption
5000001 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1351 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
26375 USD
CY2015Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1321 USD
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2015Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
100000 USD
CY2015Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
25000 USD
CY2016Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2015Q2 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
10000 USD
CY2016Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 USD
CY2016Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
10000 USD
CY2015Q2 gpiau Underwriters Deferred Discount Amount
UnderwritersDeferredDiscountAmount
6037500 USD
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7951 USD
CY2016Q1 gpiau Working Capital Loan
WorkingCapitalLoan
1000000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
975400 USD
CY2015Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
172578252 USD
CY2015Q4 us-gaap Assets
Assets
173553652 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19968 USD
CY2015Q2 gpiau Underwriters Discount Percentage
UnderwritersDiscountPercentage
0.060 pure
CY2015Q2 gpiau Payments To Underwriters In Cash
PaymentsToUnderwritersInCash
4312500 USD
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5425188 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5425188 shares
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
173553652 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
5000001 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130726 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2015Q4 us-gaap Deferred Long Term Liability Charges
DeferredLongTermLiabilityCharges
6037500 USD
CY2015Q4 us-gaap Liabilities
Liabilities
6057468 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5130195 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
532 USD
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5320250 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5320250 shares
CY2016Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1066912 USD
CY2015Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
9351 USD
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
162496183 USD
CY2016Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
16137312 shares
CY2015Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
16242250 shares
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9351 USD
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2016Q1 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
103291 USD
CY2015Q1 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
0 USD
CY2016Q1 gpiau Offered Costs Incurred As Part Of Accrued Offering Costs
OfferedCostsIncurredAsPartOfAccruedOfferingCosts
0 USD
CY2015Q1 gpiau Offered Costs Incurred As Part Of Accrued Offering Costs
OfferedCostsIncurredAsPartOfAccruedOfferingCosts
232000 USD
CY2016Q1 gpiau Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
-802394 USD
CY2015Q1 gpiau Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
0 USD
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><i><font style="FONT-SIZE: 10pt">Use of estimates</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><i><font style="FONT-SIZE: 10pt">Concentration of credit risk</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. At March 31, 2016, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2015-01-28
CY2016Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
172842770 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 us-gaap Interest Income Other
InterestIncomeOther
239000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
562500 shares
CY2016Q1 gpiau Contingent Transaction Fee Amount
ContingentTransactionFeeAmount
1881000 USD
CY2016Q1 gpiau Committed Transaction Fee Amount
CommittedTransactionFeeAmount
16894000 USD
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3750000 shares
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5320250 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2015Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
0 shares

Files In Submission

Name View Source Status
0001144204-16-102796-index-headers.html Edgar Link pending
0001144204-16-102796-index.html Edgar Link pending
0001144204-16-102796.txt Edgar Link pending
0001144204-16-102796-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gpiau-20160331.xml Edgar Link completed
gpiau-20160331.xsd Edgar Link pending
gpiau-20160331_cal.xml Edgar Link unprocessable
gpiau-20160331_def.xml Edgar Link unprocessable
gpiau-20160331_lab.xml Edgar Link unprocessable
gpiau-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v438861_10q.htm Edgar Link pending
v438861_ex31.htm Edgar Link pending
v438861_ex32.htm Edgar Link pending